Qing Xiaoping, Zavadil Jiri, Crosby Michelle B, Hogarth Mark P, Hahn Bevra H, Mohan Chandra, Gilkeson Gary S, Bottinger Erwin P, Putterman Chaim
Division of Rheumatology, Forchheimer 701N, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Arthritis Rheum. 2006 Jul;54(7):2198-210. doi: 10.1002/art.21934.
Lupus-associated IgG anti-double-stranded DNA antibodies are thought to be pathogenic in the kidney due to cross-reaction with glomerular antigens, leading subsequently to immune complex formation in situ and complement activation. We undertook this study to determine if pathogenic anti-DNA antibodies may also contribute to renal damage by directly influencing mesangial gene expression.
Complementary DNA microarray gene profiling was performed in primary mesangial cells (derived from lupus-prone MRL/lpr mice) treated with pathogenic, noncomplexed anti-DNA antibodies. Significant gene up-regulation induced by anti-DNA antibodies as determined by microarray analysis was further investigated by real-time polymerase chain reaction and methods to detect the relevant proteins. Induction of proinflammatory genes by pathogenic antibodies was confirmed by comparing gene expression in glomeruli of old versus young MRL/lpr mice, and by antibody injection in vivo.
Pathogenic, but not nonpathogenic, antibodies significantly induced a number of transcripts, including CXCL1/KC, LCN2, iNOS, CX3CL1/fractalkine, SERPINA3G, and IkappaBalpha ("marker genes"). Blocking of Fcgamma receptors or using Fcgamma chain-knockout mesangial cells had no effect on the gene regulation effect of the pathogenic antibody R4A, indicating a non-Fc-dependent mechanism. The glomerular expression of these marker genes increased over time with the development of glomerular antibody deposition and active nephritis in MRL/lpr mice. Moreover, injection of R4A into SCID mice in vivo significantly up-regulated glomerular marker gene expression.
These findings indicate that the renal pathogenicity of anti-DNA antibodies may be attributed in part to their ability to directly modulate gene expression in kidney mesangial cells through both Fc-dependent and non-Fc-dependent mechanisms.
狼疮相关的IgG抗双链DNA抗体被认为因其与肾小球抗原的交叉反应而在肾脏中具有致病性,随后导致原位免疫复合物形成和补体激活。我们进行这项研究以确定致病性抗DNA抗体是否也可能通过直接影响系膜基因表达而导致肾损伤。
在用致病性、非复合抗DNA抗体处理的原代系膜细胞(源自狼疮易感MRL/lpr小鼠)中进行互补DNA微阵列基因谱分析。通过微阵列分析确定的抗DNA抗体诱导的显著基因上调通过实时聚合酶链反应和检测相关蛋白质的方法进一步研究。通过比较老年与年轻MRL/lpr小鼠肾小球中的基因表达以及通过体内抗体注射来证实致病性抗体对促炎基因的诱导。
致病性而非非致病性抗体显著诱导了许多转录本,包括CXCL1/KC、LCN2、iNOS、CX3CL1/趋化因子、SERPINA3G和IkappaBalpha(“标记基因”)。阻断Fcγ受体或使用Fcγ链敲除的系膜细胞对致病性抗体R4A的基因调节作用没有影响,表明这是一种非Fc依赖性机制。随着MRL/lpr小鼠肾小球抗体沉积和活动性肾炎的发展,这些标记基因的肾小球表达随时间增加。此外,将R4A体内注射到SCID小鼠中显著上调了肾小球标记基因的表达。
这些发现表明抗DNA抗体的肾脏致病性可能部分归因于它们通过Fc依赖性和非Fc依赖性机制直接调节肾脏系膜细胞基因表达的能力。